miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer
- 1 March 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 6 (3), 482-488
- https://doi.org/10.1097/jto.0b013e318208c785
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Early detection of lung adenocarcinoma in sputum by a panel of microRNA markersInternational Journal of Cancer, 2010
- Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non–Small Cell Lung Cancer from Patients with Nonmalignant Lung DiseaseCancer Research, 2009
- miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experimentsBMC Cancer, 2009
- A gene-based risk score for lung cancer susceptibility in smokers and ex-smokersPostgraduate Medical Journal, 2009
- The CREST Biorepository: A Tool for Molecular Epidemiology and Translational Studies on Malignant Mesothelioma, Lung Cancer, and Other Respiratory Tract DiseasesCancer Epidemiology, Biomarkers & Prevention, 2008
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008
- Computed Tomography Screening and Lung Cancer OutcomesPublished by American Medical Association (AMA) ,2007
- CT Screening for Lung Cancer: Five-year Prospective ExperienceRadiology, 2005
- Early Lung Cancer Action ProjectAnnals of the New York Academy of Sciences, 2001